Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1831]

Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated with systemic drug therapies

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated...

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

Scientists look for microscopic clues to beating deadly brain tumors

Scientists look for microscopic clues to beating deadly brain tumors

Anti-cancer drugs, olaparib and adavosertib, work best when given sequentially in patients with advanced tumours driven by DNA damage response mutations: results from phase Ib STAR clinical trial

Anti-cancer drugs, olaparib and adavosertib, work best when given sequentially in patients with advanced tumours...

Advanced nanoparticles provide new weapon to fight difficult cancers

Advanced nanoparticles provide new weapon to fight difficult cancers

Researchers identify specific alterations in the BRAF gene that may affect response to treatment and survival in adult brain cancers

Researchers identify specific alterations in the BRAF gene that may affect response to treatment and survival in...

Gene mutations in tumours impact radiation sensitivity

Gene mutations in tumours impact radiation sensitivity

Statistics show an average of 789 new malignant cancers diagnosed a day in the UK in 2020

Statistics show an average of 789 new malignant cancers diagnosed a day in the UK in 2020

New cancer drug candidate targets immune system “brakes”

New cancer drug candidate targets immune system “brakes”

More from ecancer